Buprenex
More Drug Shortages in Fungal Meningitis Aftermath »
"Nov. 2, 2012 -- Safety steps taken in the wake of the fungal meningitis outbreak have worsened drug shortages, raising questions about whether the U.S. must choose between the safety and the availability of crucial medicines.
Ameridos"...
Read the More Drug Shortages in Fungal Meningitis Aftermath article »
Buprenex
Buprenex®
(buprenorphine hydrochloride) Injectable
DRUG DESCRIPTION
Proprietary name: Buprenex
Established name: buprenorphine HCI
Route of administration: INTRAVENOUS (C38276), INTRAMUSCULAR (C28161)
Active ingredients (moiety): buprenorphine HCI (buprenorphine)
| # | Strength | Form | Inactive ingredients |
| 1 | 0.324 : 1 | INJECTION, SOLUTION ( C42945) | anhydrous dextrose, water for injection, hydrochloric acid |
Buprenex (buprenorphine hydrochloride) is a narcotic under the Controlled Substances Act due to its chemical derivation from thebaine. Chemically, it is 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4, 5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6, 14- ethenomorphinan-7-methanol, hydrochloride [5α, 7α(S)]. Buprenorphine hydrochloride is a white powder, weakly acidic and with limited solubility in water. Buprenex (buprenorphine) is a clear, sterile, injectable agonist-antagonist analgesic intended for intravenous or intramuscular administration. Each ml of Buprenex contains 0.324 mg buprenorphine hydrochloride (equivalent to 0.3 mg buprenorphine), 50 mg anhydrous dextrose, water for injection and HCI to adjust pH. Buprenorphine hydrochloride has the molecular formula, C29H41NO4HCI, and the following structure:
![]() |
Last reviewed on RxList: 4/22/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Buprenex Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.







